Literature DB >> 25196852

Characterisation of gamma delta (γδ) T cell populations in patients with sepsis.

Helen F Galley1, Damon A Lowes, Keith Thompson, Naomi D Wilson, Carol A Wallace, Nigel R Webster.   

Abstract

Gamma delta (γδ) T cells contribute to both innate and acquired immune responses during infection. In this pilot study, we measured the in vitro responses of γδT cell populations from patients with sepsis compared to cells from healthy subjects. We also measured production of interferon (IFN)γ. Mononuclear cells were isolated from 10 healthy control subjects and 20 patients with sepsis. Cells were cultured for 7 days with interleukin (IL)-2 plus the bisphosphonate zoledronic acid which results in indirect cell activation. Flow cytometry was used to characterise the γδT cells and enzyme immunoassay was used to measure IFNγ production. The median [range] proportion of γδT cells in healthy controls after activation was 19.2% [2.0-55.9%], compared to only 0.61% [0.1-3.6%] (P < 0.0001) in patients with sepsis. However, IFNγ levels in culture supernatants were similar in both the patients and healthy subjects. We therefore characterised the cells further by CD27 and CD45RA expression in a additional group of patients and found that the population of γδT cells was mainly CD27 negative which characterised these cells as non-proliferating effector cells. Our results suggest predominance of a non-proliferative effector subset of γδT cells in patients with sepsis, which retain functional activity and may contribute towards the host response to inflammation and infection.
© 2014 International Federation for Cell Biology.

Entities:  

Keywords:  gamma delta T cells; infection; interferon gamma; interleukin-2; sepsis; zoledronic acid

Mesh:

Substances:

Year:  2014        PMID: 25196852     DOI: 10.1002/cbin.10361

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  7 in total

Review 1.  New insights into the gut as the driver of critical illness and organ failure.

Authors:  Mei Meng; Nathan J Klingensmith; Craig M Coopersmith
Journal:  Curr Opin Crit Care       Date:  2017-04       Impact factor: 3.687

Review 2.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

3.  E. coli promotes human Vγ9Vδ2 T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner.

Authors:  M Barisa; A M Kramer; Y Majani; D Moulding; L Saraiva; M Bajaj-Elliott; J Anderson; K Gustafsson
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

Review 4.  γδ T Cells in Antimalarial Immunity: New Insights Into Their Diverse Functions in Protection and Tolerance.

Authors:  Kathleen W Dantzler; Prasanna Jagannathan
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

Review 5.  Toll-like receptors in immunity and inflammatory diseases: Past, present, and future.

Authors:  Kumar Vijay
Journal:  Int Immunopharmacol       Date:  2018-05-04       Impact factor: 4.932

Review 6.  A diversified role for γδT cells in vector-borne diseases.

Authors:  Chen Chen; Aibao Chen; Yanan Yang
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

7.  Extreme prematurity and sepsis strongly influence frequencies and functional characteristics of circulating γδ T and natural killer cells.

Authors:  Khaleda Rahman Qazi; Georg B Jensen; Marieke van der Heiden; Sophia Björkander; Giovanna Marchini; Maria C Jenmalm; Thomas Abrahamsson; Eva Sverremark-Ekström
Journal:  Clin Transl Immunology       Date:  2021-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.